Liquid chromatography-tandem mass spectrometry method for the quantification of deglymidodrine in human plasma

被引:13
作者
Jia, JY
Liu, GY
Li, SJ
Li, XC
Yuan, WF
Yu, C [1 ]
Wang, YP
机构
[1] Shanghai Xuhui Cent Hosp, Cent Lab, Shanghai 200031, Peoples R China
[2] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China
[3] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Mat Med, Dept Med Chem, Shanghai 201203, Peoples R China
关键词
deglymidodrine; midodrine; LC-MS/MS; pharmacokinetic; plasma;
D O I
10.1016/j.jpba.2005.08.015
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A simple, rapid and sensitive liquid chromatography-tandem mass spectrometry method was developed for quantification of deglymidodrine in human plasma. The plasma samples were pretreated by protein precipitation with trichloroacetate. The chromatographic separation was performed on reversed phase Aquasil C-18 column, and the plasma extraction was eluted with a mobile phase solution consisting of acetonitrile (containing 0.02% formic acid) and water (containing 0.02% formic acid). The molecular ion of analyte was detected in positive ionization by multiple reaction monitoring. The mass transitions of m/z 198.4 -> 148.1 and m/z 212.4 -> 162.3 were used for detection of deglymidodrine and its internal standard, respectively. The assay exhibited linear ranges from 0.25 to 32 ng/ml for the analyte in human plasma. Acceptable precision and accuracy were obtained for concentrations of quality control (QC) samples. The proposed method has been successfully used to analyze human plasma samples for application in oral pharmacokinetic study. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:715 / 719
页数:5
相关论文
共 10 条
[1]   The in vitro metabolism of desglymidodrine, an active metabolite of prodrug midodrine by human liver microsomes [J].
Akimoto, M ;
Iida, I ;
Itoga, H ;
Miyata, A ;
Kawahara, S ;
Kohno, Y .
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2004, 29 (03) :179-186
[2]  
GILDEN JL, 1993, INT ANGIOL, V12, P125
[3]  
GROBECKER H, 1987, ARZNEIMITTEL-FORSCH, P447
[4]   Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension - A randomized, double-blind multicenter study [J].
Low, PA ;
Gilden, JL ;
Freeman, R ;
Sheng, KN ;
McElligott, MA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (13) :1046-1051
[5]   MIDODRINE - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC USE IN ORTHOSTATIC HYPOTENSION AND SECONDARY HYPOTENSIVE DISORDERS [J].
MCTAVISH, D ;
GOA, KL .
DRUGS, 1989, 38 (05) :757-777
[6]   Human α1-glycoprotein acid as chiral selector in the enantioseparation of midodrine and deglymidodrine racemates by HPLC [J].
Quaglia, MG ;
Farina, A ;
Bossù, E ;
Cotichini, V .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1998, 18 (1-2) :171-177
[7]   Successful treatment of hypotension associated with stunned myocardium with oral Midodrine therapy [J].
Sharma, S ;
Bhambi, B .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2005, 10 (01) :77-79
[8]   Efficacy of midodrine hydrochloride in neurocardiogenic syncope refractory to standard therapy [J].
Sra, J ;
Maglio, C ;
Biehl, M ;
Dhala, A ;
Blanck, Z ;
Deshpande, S ;
Jazayeri, MR ;
Akhtar, M .
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 1997, 8 (01) :42-46
[9]   VASOCONSTRICTOR EFFECT OF MIDODRINE, ST 1059, NORADRENALINE, ETILEFRINE AND DIHYDROERGOTAMINE ON ISOLATED HUMAN VEINS [J].
THULESIUS, O ;
GJORES, JE ;
BERLIN, E .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 16 (06) :423-424
[10]   OBSERVATIONS ON MIDODRINE IN A CASE OF VASODEPRESSOR NEUROGENIC SYNCOPE [J].
WARD, C ;
KENNY, RA .
CLINICAL AUTONOMIC RESEARCH, 1995, 5 (05) :257-260